C)
Fluorescence intensity of GFP-labeled Sp3GH98 CD on the cell surface under different crowding conditions. RBCs were coated with 200 µL of crowder solutions containing GFPSp3GH98 E558A CD (1.3 nmol/ml). The values were obtained by measuring the fluorescence intensity at three randomly chosen spots (45000 µm 2 ) on cell surfaces. The arrows indicate the fluorescence intensity at the glass surface, and asterisks indicate the fluorescence on the cell surface, which is located ~ 2-3 µm above the glass surface. RBCs were immobilized on a glass slide using poly(L-lysine) and glutaraldehyde. The fluorescence intensity on the cell surface was measured using a Nikon C2+ Eclipse Ti-E Confocal microscope 10 min after the addition of enzyme to the cells.
D -F)
Effect of 40 kDa dextran concentration on the fluorescence intensity of GFP-labeled Sp3GH98 E558A CD (200 µL, 1.3 nmol/ml) immobilized on glass surface, using poly(L-lysine) and glutaraldehyde. Non-bound enzyme was washed away, and immobilized enzyme was covered with different concentration of crowder solutions.
D)
Representative 3D confocal images of GFP-labeled Sp3GH98 E558A CD immobilized on glass surface, in the presence of different concentrations of 40 kDa dextran.
E)
Representative fluorescence intensity values of areas of 45000 µm 2 of GFP-labeled Sp3GH98 E558A CD immobilized on the glass surface at different crowding conditions. F) Normalized intensity of GFP-labeled Sp3GH98 E558A CD on the glass surface at different concentrations of 40 kDa dextran. The values were obtained by measuring fluorescence intensity at three randomly chosen spots (45000 µm 2 area) on the glass surface.
Supplementary Figure 6:
Fluorescence recovery after photobleaching measurements in bulk solution and on RBC surface.
A)
Representative results from measurement of the fluorescence recovery after photobleaching of GFP-Sp3GH98 E558A CD in bulk solution in PBS pH 7.4 containing different concentrations of 40 kDa dextran. A circular region with a radius of 5.5 µm was bleached for 1.95 s using 40 -60 % of laser power at 488 nm (11 mW) and the recovery was monitored with time using an x 60 oil objective. A layer of PBS buffer or crowder (200 µL) containing GFP-Sp3GH98 E558A CD (1.3 nmol/ml) was added and the enzyme allowed to equilibrate for 10 min before measurements. B) The mobile fraction of GFP-Sp3GH98 E558A CD both in bulk solution and on the cell surface, calculated from the fluorescence intensity of the bleached area, before and after bleaching and after recovery, using equation (5) 1 . Data points represent the average of three experimental measurements and the error bars are the standard deviation around the mean.
C) The fluorescence recovery of GFP-Sp3GH98 E558A CD on the cell surface in 40 kDa dextran (320 mg/ml) using cell surface glutaraldehyde-immobilized GFP-Sp3GH98 E558A CD. A layer of PBS buffer or crowder (200 µL) containing GFP-Sp3GH98 E558A CD (1.3 nmol/ml) with or without glutaraldehyde (6 %) was equilibrated for 3 h at room temperature before measurements.
Supplementary Figure 7:
Fluorescence intensity measured as a function of time on glass and cell surfaces during the enzyme exchange. A layer of PBS buffer or crowder (75 µL) that contains GFP-Sp3GH98 E558A CD (1.3 nmol/ml) was added initially and the enzyme allowed to equilibrate for 10 min, followed by the careful addition of PBS buffer or crowder (75 µL) that contains CFP-Sp3GH98 E558A CD (10.7 nmol/ml). A) Representative confocal microscopy images of cells initially coated with GFP-Sp3GH98 E558A (a) and then overlaid with a layer of CFP-Sp3GH98 E558A CD containing different amounts of crowder collected at different time points using the green channel at 488 nm 
B)
Binding of murine anti human CD 47 antibody to the corresponding antigen in the presence of different concentrations of crowders (100 -300 mg/ml). Phycoerythrin (PE) monoclonal anti CD47 (5 µL, 0.5 % BSA, pH = 7.4) was added to RBCs (100 µL, 1 % Hematocrit) in PBS or 40 kDa dextran solutions, and incubated at RT for 30 min in the dark. RBCs were washed with saline and analyzed. Results were analyzed by flow cytometry, acquiring 10000 events using the 
C)
Removal of sialic acid using a neuraminidase in the presence of different concentrations of crowders (100 -300 mg/ml). RBCs (400 µL, 10 % hematocrit) in PBS pH 6 containing different concentration of crowders were treated with neuraminidase from Clostridium Perfringens at 0.0075 and 0.06 U/ml for 1 h at room temperature, washed with saline and analyzed. The extent of sialic acid removal was evaluated by measuring the electrophoretic mobility of cells in 154 mM saline. Sialic acid provides negative charges to the cell surface, thus affects the electrophoretic mobility of the cell in a charged field. Results represent the average mobility of 10 individual cells, and error bars are standard deviations around the mean. A decrease in electrophoretic mobility indicates a better removal of sialic acid from cell surface. A) Producing enzymatically converted universal donor RBCs as illustrated by converting AB group blood to O group blood under crowded conditions. Blood conversion was evaluated using FDA approved Micro Typing System (MTS) cards. AB group blood (10 % Hematocrit) was treated respectively with α-N-acetyl-galactosaminidase (EmGH109, 1 nmol/ml) and Sp3GH98 CD (0.057 nmol/ml) in PBS or in 40 kDa dextran (300 mg/ml) for 1 hr each at room temperature (22C) and the cells are washed 3 times to remove the dextran and residual enzymes. The extent of antigen removal was evaluated using a score from 0 to +4, according to the manufacturer's instructions; a positive control has a score of +4 indicative of high antigen levels on the cell surface, and 0 indicates the absence (complete removal) of antigens from the cell surface. Significantly lower amounts of enzymes were required for the complete removal of surface antigens in the presence of crowder dextran.
B)
The osmotic fragility of RBCs that have been enzymatically converted under crowded conditions. RBCs were treated with Sp3GH98 CD (0.043 nmol/ml) for 1 h at room temperature in the absence and presence of 300 mg/ml of 40 kDa dextran, 30 kDa HPG and 70 kDa ficoll at pH 7.4 at room temperature (22C). After washing with saline, cells were placed in different concentrations of NaCl solutions for 1 h at room temperature (22 °C), and hemolysis was measured using Drabkin's reagent. Osmotic fragility curves of the RBCs treated in presence of crowder are similar to control cells suggest no membrane damage. In panels C and D, the normal ranges of RBC mean corpuscular volume and mean corpuscular hemoglobin concentrations were identified (dotted lines), according to ADVIA 120 Hematology System manufacturers' guidance. In panels E and F, data did not differ significantly from the control (P < 0.05).
RBCs were treated with Sp3GH98 C (0.043 nmol/ml) for 1 h at room temperature (22°C) in the absence and presence of 300 mg/ml of 40 kDa dextran at pH 7.4. After washing, cells were stored at 40 % Hematocrit at 4 °C in 1.5 ml eppendorf tubes in a saline solution, supplemented with 10 % plasma and 25 % SAGM (sodium chloride, adenine, glucose and mannitol) solution, according to storage procedures adopted from the Canadian Blood Services. It should be noted that storage in small containers without proper oxygen exchange may introduce additional stress to RBCs, unlike the situation in 400 mL blood storage bags. Enzymatic treatment of RBCs in the presence of 40 kDa dextran did not alter the structural and functional integrity of RBCs. In panel E, data did not differ significantly from the control (P < 0.05).
RBCs were treated with EmGH109 (1 nmol/ml) for 1 h at room temperature in the absence and presence of 300 mg/ml of 40 kDa dextran at pH 7.4 at room temperature (22°C). After washing cells were stored at 40 % Hematocrit at 4 °C in 1.5 ml eppendorf tubes in a saline solution, supplemented with 10 % plasma and 25 % SAGM (sodium chloride, adenine, glucose and mannitol) solution, according to storage procedures adopted from the Canadian Blood Services. It should be noted that storage in small containers without proper oxygen exchange may introduce additional stress to RBCs compared to the situation in 400 mL blood storage bags. Enzymatic treatment of RBCs in the presence of 40 kDa dextran did not alter the structural and functional integrity of RBCs.
